- Preview Available
- Scholarly Journal
The MEK inhibitor trametinib is effective in inhibiting the growth of canine oral squamous cell carcinoma
Scientific Reports (Nature Publisher Group); London Vol. 15, Iss. 1, (2025): 7069.
DOI:10.1038/s41598-025-90574-3
This is a limited preview of the full PDF
Try and log in through your library or institution to see if they have access.